Humana Inc. (NYSE:HUM) Shares Acquired by CCLA Investment Management

CCLA Investment Management grew its stake in shares of Humana Inc. (NYSE:HUM) by 1.0% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 316,913 shares of the insurance provider’s stock after purchasing an additional 3,227 shares during the period. Humana comprises about 1.8% of CCLA Investment Management’s holdings, making the stock its 26th biggest holding. CCLA Investment Management’s holdings in Humana were worth $115,257,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also modified their holdings of the company. CarsonAllaria Wealth Management Ltd. lifted its position in shares of Humana by 111.4% in the second quarter. CarsonAllaria Wealth Management Ltd. now owns 74 shares of the insurance provider’s stock worth $28,000 after buying an additional 39 shares during the last quarter. Hantz Financial Services Inc. bought a new position in shares of Humana in the second quarter valued at approximately $35,000. Family Firm Inc. bought a new stake in shares of Humana during the second quarter worth $37,000. Riverview Trust Co acquired a new stake in Humana in the 2nd quarter valued at about $44,000. Finally, Carolinas Wealth Consulting LLC raised its position in Humana by 274.1% in the 4th quarter. Carolinas Wealth Consulting LLC now owns 101 shares of the insurance provider’s stock worth $46,000 after purchasing an additional 74 shares during the last quarter. Institutional investors and hedge funds own 92.38% of the company’s stock.

Analysts Set New Price Targets

HUM has been the topic of a number of recent research reports. Morgan Stanley initiated coverage on shares of Humana in a research note on Monday, June 24th. They issued an “equal weight” rating and a $374.00 price objective on the stock. Royal Bank of Canada raised their target price on shares of Humana from $385.00 to $400.00 and gave the stock an “outperform” rating in a report on Thursday, September 5th. Robert W. Baird assumed coverage on Humana in a research report on Thursday, May 30th. They set a “neutral” rating and a $374.00 price target for the company. Truist Financial boosted their target price on shares of Humana from $355.00 to $400.00 and gave the stock a “hold” rating in a report on Monday, July 15th. Finally, Cantor Fitzgerald reissued a “neutral” rating and issued a $395.00 price objective on shares of Humana in a research report on Tuesday, September 10th. Thirteen research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $398.70.

Humana Stock Performance

Humana stock opened at $311.85 on Wednesday. The company has a current ratio of 1.66, a quick ratio of 1.66 and a debt-to-equity ratio of 0.70. Humana Inc. has a 1-year low of $298.61 and a 1-year high of $530.54. The firm has a 50-day moving average of $361.77 and a 200-day moving average of $346.39. The firm has a market cap of $37.58 billion, a P/E ratio of 19.42, a P/E/G ratio of 2.56 and a beta of 0.50.

Humana (NYSE:HUM) last announced its earnings results on Wednesday, July 31st. The insurance provider reported $6.96 earnings per share for the quarter, beating analysts’ consensus estimates of $5.89 by $1.07. The business had revenue of $29.54 billion during the quarter, compared to the consensus estimate of $28.52 billion. Humana had a net margin of 1.53% and a return on equity of 16.12%. The business’s revenue for the quarter was up 10.4% on a year-over-year basis. During the same quarter last year, the firm earned $8.94 earnings per share. Sell-side analysts expect that Humana Inc. will post 16 EPS for the current year.

Humana Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, October 25th. Shareholders of record on Monday, September 30th will be given a $0.885 dividend. This represents a $3.54 dividend on an annualized basis and a yield of 1.14%. The ex-dividend date of this dividend is Monday, September 30th. Humana’s dividend payout ratio (DPR) is presently 22.04%.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.